10,000+ stock pitches from top investors available on joinyellowbrick.com
RA CAPITAL MANAGEMENT, L.P. 13F Holdings
Holdings from the most recent 13F from RA CAPITAL MANAGEMENT, L.P.
Filed: 2024-11-14 (Q3 2024) | Holdings: 82 | Value: $8.7B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
|---|---|---|---|---|---|---|---|
| Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
| ASND - ASCENDIS PHARMA A/S - ADR | Reduce 4% $(59.4M) | 16.72% | $1.4B | +49.23% | +31.27% | ||
| PCVX - VAXCYTE INC | Add 6% ($55.5M) | 11.45% | $992.9M | -62.12% | -10.22% | ||
| JANX - JANUX THERAPEUTICS INC | 4.80% | $416.4M | -50.88% | -26.42% | |||
| LEGN - LEGEND BIOTECH CORP-ADR | 4.22% | $365.8M | -21.08% | -4.19% | |||
| RYTM - RHYTHM PHARMACEUTICALS INC | 3.68% | $318.8M | +9.92% | -4.42% | |||
| RNA - AVIDITY BIOSCIENCES INC | Add 17% ($41.3M) | 3.34% | $289.4M | -29.27% | -36.41% | ||
| TYRA - TYRA BIOSCIENCES INC | 2.82% | $244.9M | -37.87% | -23.09% | |||
| EVH - EVOLENT HEALTH INC - A | 2.78% | $240.8M | -36.07% | -21.00% | |||
| EWTX - EDGEWISE THERAPEUTICS INC | 2.74% | $237.8M | -55.10% | -20.84% | |||
| BIIB - BIOGEN INC | Add 21% ($39.2M) | 2.65% | $229.6M | -21.21% | -17.46% | ||
| DYN - DYNE THERAPEUTICS INC | Add 5% ($11.9M) | 2.64% | $229.2M | -54.31% | -55.00% | ||
| RXST - RXSIGHT INC | Add 6% ($11.0M) | 2.23% | $193.6M | -66.79% | -31.43% | ||
| BCAX - BICARA THERAPEUTICS INC | New Purchase | 2.04% | $177.2M | -50.36% | -41.09% | ||
| SPRY - ARS PHARMACEUTICALS INC | 1.82% | $157.5M | -5.29% | -17.05% | |||
| ACLX - ARCELLX INC | Add 15% ($20.7M) | 1.78% | $154.6M | -30.20% | -32.30% | ||
| ARTV - ARTIVA BIOTHERAPEUTICS INC | New Purchase | 1.76% | $152.2M | -82.07% | -62.49% | ||
| WVE - WAVE LIFE SCIENCES LTD | 1.72% | $149.3M | -55.53% | -27.34% | |||
| CLYM - CLIMB BIO INC | 1.70% | $147.3M | -61.61% | -52.63% | |||
| GERN - GERON CORP | Reduce 30% $(63.2M) | 1.69% | $146.6M | -58.18% | -29.49% | ||
| VRNA - VERONA PHARMA PLC - ADR | Reduce 34% $(75.5M) | 1.66% | $144.1M | +144.33% | +83.52% | ||
| NAMS - NEWAMSTERDAM PHARMA CO NV | 1.54% | $133.9M | -21.96% | -19.84% | |||
| APGE - APOGEE THERAPEUTICS INC | 1.33% | $115.2M | -26.36% | -31.68% | |||
| DAWN - DAY ONE BIOPHARMACEUTICALS I | 1.26% | $109.7M | -51.57% | -16.86% | |||
| ETNB - 89BIO INC | 1.21% | $104.9M | +12.54% | +23.39% | |||
| RXRX - RECURSION PHARMACEUTICALS-A | 1.17% | $101.4M | -33.67% | +54.43% | |||
| LENZ - LENZ THERAPEUTICS INC | 1.14% | $99.2M | -10.88% | -26.97% | |||
| PEPG - PEPGEN INC | 1.05% | $91.4M | -68.72% | -69.16% | |||
| AXSM - AXSOME THERAPEUTICS INC | 1.04% | $89.9M | +13.14% | +30.96% | |||
| GPCR - STRUCTURE THERAPEUTICS INC | 0.96% | $83.2M | -43.13% | -39.81% | |||
| TRML - TOURMALINE BIO INC | 0.75% | $65.3M | -29.59% | -51.02% | |||
| DNTH - DIANTHUS THERAPEUTICS INC | 0.74% | $63.9M | -27.32% | -5.21% | |||
| MLYS - MINERALYS THERAPEUTICS INC | 0.68% | $58.7M | +27.30% | -21.76% | |||
| ACRV - ACRIVON THERAPEUTICS INC | 0.67% | $58.4M | -84.38% | -34.25% | |||
| ATXS - ASTRIA THERAPEUTICS INC | Add 1% ($676.6K) | 0.65% | $56.2M | -48.67% | -31.27% | ||
| FDMT - 4D MOLECULAR THERAPEUTICS IN | 0.64% | $55.1M | -51.91% | -40.34% | |||
| CGON - CG ONCOLOGY INC | 0.61% | $52.7M | -25.68% | -23.61% | |||
| BCYC - BICYCLE THERAPEUTICS PLC-ADR | 0.59% | $51.0M | -62.47% | -46.31% | |||
| NKTX - NKARTA INC | 0.56% | $48.8M | -32.22% | -15.93% | |||
| BIOA - BIOAGE LABS INC | New Purchase | 0.53% | $46.0M | -77.80% | -78.10% | ||
| GHRS - GH RESEARCH PLC | Add 1% ($568.7K) | 0.52% | $44.7M | +29.60% | +43.94% | ||
| PRAX - PRAXIS PRECISION MEDICINES I | Reduce 38% $(27.3M) | 0.51% | $43.8M | -44.81% | +2.72% | ||
| IDYA - IDEAYA BIOSCIENCES INC | New Purchase | 0.49% | $42.7M | -28.38% | -30.62% | ||
| LRMR - LARIMAR THERAPEUTICS INC | 0.46% | $39.6M | -67.59% | -56.79% | |||
| MBX - MBX BIOSCIENCES INC | New Purchase | 0.45% | $39.3M | -38.55% | -43.52% | ||
| ABOS - ACUMEN PHARMACEUTICALS INC | 0.43% | $37.0M | -59.16% | -44.66% | |||
| FULC - FULCRUM THERAPEUTICS INC | Reduce 12% $(4.9M) | 0.42% | $36.5M | +115.45% | +14.24% | ||
| ITOS - ITEOS THERAPEUTICS INC | Reduce 9% $(3.4M) | 0.37% | $32.5M | +18.65% | -13.29% | ||
| SLDB - SOLID BIOSCIENCES INC | 0.35% | $30.2M | -20.71% | -1.12% | |||
| CCCC - C4 THERAPEUTICS INC | New Purchase | 0.32% | $27.8M | -69.18% | -37.74% | ||
| ELVN - ENLIVEN THERAPEUTICS INC | Reduce 50% $(27.1M) | 0.31% | $27.1M | -14.52% | -12.72% | ||
| LBPH - LONGBOARD PHARMACEUTICALS IN | Reduce 100% | 0.00% | $0.00 | ||||
| TSHA - TAYSHA GENE THERAPIES INC | Reduce 100% | 0.00% | $0.00 | ||||
| TNYA - TENAYA THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| THRD - THIRD HARMONIC BIO INC | Reduce 100% | 0.00% | $0.00 | ||||
| VOR - VOR BIOPHARMA INC | Reduce 100% | 0.00% | $0.00 | ||||
| URGN - UROGEN PHARMA LTD | Reduce 100% | 0.00% | $0.00 | ||||